Co-administration of low concentrations of matrix metalloproteinase 2, myosin light chain kinase and nitric oxide synthase inhibitors protects heart from ischemia/reperfusion injury
Event:
ESC Congress 2017
Topic:
Infarction acute phase STEMI
Session:
Latest on STEMI
